Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125834052 | 12583405 | 2 | F | 20160729 | 20160722 | 20160803 | EXP | US-PFIZER INC-2016350429 | PFIZER | KARLI, B.. REVERSAL STRATEGIES FOR INTRACRANIAL HEMORRHAGES IN PATIENTS TAKING ORAL FACTOR XA INHIBITORS.. HOSPITAL PHARMACY. 2015;50 (7):569-577 | 84.00 | YR | M | Y | 71.00000 | KG | 20160803 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125834052 | 12583405 | 1 | PS | AMIODARONE HCL | AMIODARONE HYDROCHLORIDE | 1 | UNK | 18972 | |||||||||||
125834052 | 12583405 | 2 | I | ASPIRIN. | ASPIRIN | 1 | 81 MG, DAILY | U | 0 | 81 | MG | ||||||||
125834052 | 12583405 | 3 | I | RIVAROXABAN | RIVAROXABAN | 1 | Oral | 20 MG, DAILY | U | 0 | 20 | MG | |||||||
125834052 | 12583405 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | 0 | |||||||||||
125834052 | 12583405 | 5 | C | CARVEDILOL. | CARVEDILOL | 1 | UNK | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125834052 | 12583405 | DE |
125834052 | 12583405 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125834052 | 12583405 | Drug interaction | |
125834052 | 12583405 | Haemorrhage intracranial |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |